For the first time, clinicians might choose therapy based on a patients dominant OSA mechanism: e.g., a weight-loss drug for an obese patient versus other interventions for a non-obese patient
Store at -20C, protected from light, moisture, and oxygen, for long-term stability
Blood clots present a risk in patients as they can potentially dislodge and travel to the lungs, blocking blood flow and causing a pulmonary embolism, which is often fatal
If desired, you can slowly increase up to 2ml/cc 1-2 times per week, or as prescribed
The 2.5 mg dose is considered the starter dose the one patients take first before they move up to higher doses until they reach their so-called maintenance doses
Then, you multiply the milliliters by the concentration of the medication